Organization, Operations and Liquidity (Product Development Pipeline) (Details)	9 Months Ended
	Sep. 30, 2015
Enclomiphene [Member] | Secondary Hypogonadism [Member]
Product Information [Line Items]
Status	NDA accepted and under review
Next Expected Milestone(s)	PDUFA date of November 30, 2015
Proellex [Member] | Uterine Fibroids [Member]
Product Information [Line Items]
Status	Phase 2
Next Expected Milestone(s)	Complete first course of treatment in a Phase 2B study (oral delivery) (Q2 2016) Complete first course of treatment in a Phase 2B study (vaginal delivery) (Q2 2016)
Proellex [Member] | Endometriosis [Member]
Product Information [Line Items]
Status	Phase 2
Next Expected Milestone(s)	Fully enroll Phase 2 study (oral delivery) (Q1 2016)